HomeCompareJCRRF vs ADC

JCRRF vs ADC: Dividend Comparison 2026

JCRRF yields 3.22% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JCRRF wins by $590.15M in total portfolio value
10 years
JCRRF
JCRRF
● Live price
3.22%
Share price
$4.17
Annual div
$0.13
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$590.33M
Annual income
$557,098,169.44
Full JCRRF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — JCRRF vs ADC

📍 JCRRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJCRRFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JCRRF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JCRRF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JCRRF
Annual income on $10K today (after 15% tax)
$273.77/yr
After 10yr DRIP, annual income (after tax)
$473,533,444.02/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, JCRRF beats the other by $473,464,766.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JCRRF + ADC for your $10,000?

JCRRF: 50%ADC: 50%
100% ADC50/50100% JCRRF
Portfolio after 10yr
$295.25M
Annual income
$278,589,483.37/yr
Blended yield
94.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

JCRRF
No analyst data
Altman Z
1.4
Piotroski
4/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JCRRF buys
0
ADC buys
0
No recent congressional trades found for JCRRF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJCRRFADC
Forward yield3.22%4.13%
Annual dividend / share$0.13$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.4%
Portfolio after 10y$590.33M$178.9K
Annual income after 10y$557,098,169.44$80,797.29
Total dividends collected$587.89M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: JCRRF vs ADC ($10,000, DRIP)

YearJCRRF PortfolioJCRRF Income/yrADC PortfolioADC Income/yrGap
1← crossover$11,344$644.17$10,990$580.36+$354.00JCRRF
2$13,504$1,365.91$12,301$860.26+$1.2KJCRRF
3$17,489$3,039.22$14,104$1,298.62+$3.4KJCRRF
4$26,070$7,356.96$16,691$2,008.16+$9.4KJCRRF
5$48,393$20,498.67$20,580$3,205.09+$27.8KJCRRF
6$122,906$71,124.57$26,754$5,330.02+$96.2KJCRRF
7$469,147$337,637.75$37,196$9,345.14+$432.0KJCRRF
8$2,910,974$2,408,986.96$56,244$17,523.09+$2.85MJCRRF
9$31,053,709$27,938,966.99$94,286$35,736.21+$30.96MJCRRF
10$590,325,638$557,098,169.44$178,949$80,797.29+$590.15MJCRRF

JCRRF vs ADC: Complete Analysis 2026

JCRRFStock

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

Full JCRRF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this JCRRF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JCRRF vs SCHDJCRRF vs JEPIJCRRF vs OJCRRF vs KOJCRRF vs MAINJCRRF vs NNNJCRRF vs EPRTJCRRF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.